News

GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 Next-Generation GLP-1 Agonists Pave The Way For Diabetes And Obesity Management
Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...
Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Research Report 2025 Market To Reach $14.34 Billion By 2034, Driven By Innovative R&D, Strategic Collaborations, And Drug ...
The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...